Experienced leader with expertise in genome engineering, stem cell biology, and complex assay development, with a broad range of experience across early R&D, including development of complex disease models, target ID and validation, hit-to-lead screening, and in vitro pharmacology. I have experience with a range of modalities, including small molecules, ASOs and recombinant proteins, and cell and gene therapy products, and in neurodegeneration, CNS and PNS neurobiology, gastrointestinal and liver diseases, immune-oncology, and immunology therapeutic areas. I have a PhD in Neuroscience from Icahn School of Medicine at Mount Sinai, published 25+ peer-reviewed articles in prestigious journals, and more than a decade of experience in working in a range of R&D settings. I have successfully built and led teams in academic, large pharma, and start-up environments. I am passionate about solving rare diseases.